| Autor: |
Smith PF; The State University of New York at Buffalo, School of Pharmacy, Department of Pharmacy Practice, Buffalo, New York 14260, USA. Pfsmith@acsu.buffalo.edu, Meadowcroft AM, May DB |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2000 Apr; Vol. 25 (2), pp. 85-99. |
| DOI: |
10.1046/j.1365-2710.2000.00274.x |
| Abstrakt: |
The incidence of dog, cat and human bites has been increasing steadily and represents an important cause of morbidity and mortality in the United States. Approximately half of all Americans will suffer a bite wound during their lifetime, and the annual medical costs of managing these injuries has been estimated to be over $100 million. Possible complications may include disfigurement, dismemberment and infection. Effective management requires rapid medical evaluation and may necessitate surgical intervention and prophylactic antibiotic therapy. As bite wounds are microbiologically diverse and most often polymicrobial in nature, selection of an appropriate antibiotic regimen requires knowledge of common pathogens. Close clinical follow-up is recommended to minimize the risk of late complications. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
